GENETiKS

What GENETiKS does

GENETiKS A.Ş. is a privately held Turkish genetic testing laboratory founded in 2006 in Istanbul, operating as a Genetic Diseases Evaluation Center under license from the Turkish Ministry of Health. The company provides a comprehensive clinical genetic testing portfolio organized into five service lines: OnkoGENETiKS (oncology genetics, including Comprehensive Genomic Profiling, a 275-gene hereditary cancer panel, breast and ovarian cancer panels, and liquid biopsy); ReproGENETiKS (preimplantation genetic testing for IVF in PGT-A, PGT-SR, and PGT-M modalities, NIPT, preconceptional carrier screening, and sperm analysis); Rare/Pediatric Disorders (CES, WES+CNV, WGS, mitochondrial DNA sequencing, microarray, and targeted mutation analysis); FarmakoGENETiKS (pharmacogenetics for drug sensitivity and toxicity); and Wellness (NutriGenetiks, GENESPORT, cardiovascular risk panel). Genetic counseling is offered as a cross-cutting service. The company claims the capability to diagnose over 20,000 genetic diseases and to offer more than 15,000 tests.

The laboratory is built on molecular diagnostic platforms including next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR), chromosomal microarray analysis, whole exome sequencing (WES), and whole genome sequencing (WGS). Through its membership in the GENDIA global genetic diagnostic network since 2007 and a strategic partnership with CENTOGENE AG (Germany), GENETiKS integrates its operations with more than 100 laboratories worldwide, extending services to patients across Turkey and in 10+ surrounding countries in Europe and the Middle East. The company maintains TURKAK ISO 15189 medical laboratory accreditation and operates a wholly-owned non-profit scientific subsidiary, Genetiks Akademi, founded in 2019 for education, research, and academic publications.

Commercially, GENETiKS runs a sales-led, healthcare provider-referral model. Tests are ordered by physicians, fertility specialists, oncology centers, and hospitals, and are processed at its single headquarters and laboratory facility at Terrace Fulya Center 2, Şişli, Istanbul. Revenue is generated on a fee-for-service, quote-based pricing model (no published price list), billed to healthcare providers, fertility clinics, hospitals, and direct patients who can also access services via call center, WhatsApp, and the company website. The company has no disclosed external funding, no parent company, and no announced acquisitions, indicating a bootstrapped, founder-managed operating model.

Name

GENETiKS

Legal name

Genetiks A.Ş.

Website

https://genetiks.com.tr

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

GENETiKS is a Turkish genetic testing laboratory founded in 2006 that provides clinical genetic diagnostics across oncology, reproductive, rare disease, pharmacogenetics, and wellness testing, serving Turkish patients and referrals from over 10 countries through its Istanbul facility.

Ownership category

akta.pro rank

Product category

Genetic Testing Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Family Planning Centers (621410)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industries

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling) (HLALAHAK)

Keywords

• Genetic testing services
• Clinical diagnostics
• Oncology genetics
• Reproductive genetics
• Prenatal screening

Headquarters

HQ city

Istanbul

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Genetic Testing Services: Laboratory-based genetic testing services including oncology, reproductive genetics, rare disease diagnostics, pharmacogenetics, and wellness testing. Revenue generated through test processing fees billed to healthcare providers, hospitals, fertility clinics, and directly to patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

GENETiKS is a licensed Genetic Diseases Evaluation Center in Istanbul offering clinical genetic testing services across oncology (OnkoGENETiKS), reproductive health (ReproGENETiKS including PGT and prenatal screening), rare/pediatric disorders, pharmacogenetics (FarmakoGENETiKS), and wellness (nutrigenetics, sport genetics). The center processes tests in its TURKAK ISO 15189 accredited laboratory using NGS, WES, WGS, FISH, PCR, and microarray technologies, and provides genetic counseling to patients and healthcare providers across Turkey and 10+ surrounding countries.

Product overview

GENETiKS is a genetic disease evaluation center offering a comprehensive portfolio of genetic testing services organized into six main service lines: OnkoGENETiKS (oncology genetics including CGP, hereditary cancer panels, breast/ovary cancer panels, and liquid biopsy), ReproGENETiKS (reproductive genetics including PGT, prenatal testing, carrier screening, sperm analysis), Nadir/Pediatrik Bozukluklar (rare/pediatric disorders including CES, WES, WGS, mitochondrial DNA sequencing, microarray), FarmakoGENETiKS (pharmacogenetics for drug sensitivity and toxicity), Wellness (NutriGenetiks, GENESPORT sport genetics, cardiovascular risk), and Genetik Danışma (genetic counseling). The center holds TURKAK ISO 15189 accreditation and operates with a network of over 100 partner laboratories globally through GENDIA. It can diagnose over 20,000 genetic diseases and offers more than 15,000 tests from a single facility in Istanbul.

Differentiator

Problem solved

Functional benefit

Brands

• OnkoGENETiKS: Comprehensive genomic profiling and cancer genetic testing services including hereditary cancer panels, breast and ovary cancer panels, and liquid biopsy testing.
• ReproGENETiKS
• FarmakoGENETiKS
• Wellness
• GENESPORT
• NIPT24
• PGT Portal

Products and services

• OnkoGENETiKS A suite of oncology genetic testing services offering Comprehensive Genomic Profiling (CGP), a 275-gene hereditary cancer panel, breast and ovary cancer gene panels, and liquid biopsy analysis for cancer management and personalized treatment guidance. Targeted at cancer patients and families with cancer history.
• ReproGENETiKS Reproductive genetics suite covering preimplantation genetic testing (PGT-A, PGT-SR, PGT-M), prenatal testing, preconceptional carrier screening, sperm FISH analysis, sperm DNA fragmentation testing, karyotyping, Y microdeletion analysis, thrombophilia panel, and endometrial receptivity/microbiome analysis. Targeted at couples undergoing IVF/ICSI and expectant parents.
• Nadir/Pediatrik Bozukluklar (Rare/Pediatric Disorders) Rare and pediatric genetic disorder testing including Clinical Exome Sequencing (CES), Whole Exome Sequencing with CNV analysis (WES+CNV), Whole Genome Sequencing (WGS), mitochondrial DNA sequencing, chromosomal microarray analysis, targeted mutation analysis, and gene sequencing. Targeted at children and families affected by rare genetic disorders.
• FarmakoGENETiKS Pharmacogenetics testing covering drug sensitivity and dose optimization as well as toxicity and targeted therapy guidance for personalized medication selection. Targeted at individuals requiring personalized medicine approaches.
• Wellness Health and wellness genetic testing including NutriGenetiks (nutrigenetic testing for personalized nutrition), GENESPORT (sport genetics for athletic performance optimization), and cardiovascular risk panel. Targeted at health-conscious individuals seeking personalized lifestyle optimization.
• Genetik Danışma (Genetic Counseling) Genetic counseling service providing risk assessment and guidance for individuals and families at risk for genetic disorders. Covers genetic disease types, counseling process, and multiple counseling specialties.
• NIPT24 Non-Invasive Prenatal Testing analyzing cell-free fetal DNA from maternal blood to screen for Down syndrome (T21), T18, T13, and other chromosomal abnormalities during pregnancy. Available as a dedicated standalone brand.
• Prosigna Breast Cancer Test Prosigna breast cancer test analyzing expression of 50 gene regions via PAM50 to determine breast cancer subtype classification for treatment guidance. Targeted at breast cancer patients requiring molecular subtyping.

Quantifiable outcome

• Can diagnose over 20,000 genetic diseases
• +1 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core and major.

• GENDIA (GENetic DIAgnostic Network)coreTechnology or Integration · 1 January 2007GENDIA is a global genetic diagnostic network with over 100 laboratories worldwide. Genetiks joined GENDIA officially in 2007, enabling integrated work with laboratories globally and extending services to patients beyond Turkey.
• CENTOGENE AG (Germany)majorStrategic or Co-development PartnerStrategic partnership with CENTOGENE, a global leader in rare genetic disease diagnosis with the world's broadest test portfolio. The partnership aims to address unmet genetic testing needs of patients, combining CENTOGENE's global expertise with Genetiks' regional experience.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat6 records

Key highlights7 records

Customer concentration

• Xx.com/genetiksglobal
• YouTubeyoutube.com/@GenetiksGlobal
• Facebookfacebook.com/GenetiksGlobal
• LinkedInlinkedin.com/company/genetiksglobal
• Instagraminstagram.com/genetiks.akademi

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GENETiKS